D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 15 050 KRW 0.67%
Market Cap: 669.1B KRW

Gross Margin
Dongkook Pharmaceutical Co Ltd

55.2%
Current
57%
Average
49%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.2%
=
Gross Profit
447.9B
/
Revenue
812.2B

Gross Margin Across Competitors

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
661.7B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
20 067.24 KRW
Undervaluation 25%
Intrinsic Value
Price
D
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.2%
=
Gross Profit
447.9B
/
Revenue
812.2B
What is the Gross Margin of Dongkook Pharmaceutical Co Ltd?

Based on Dongkook Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 55.2%.

Back to Top